Recently, the impact of Human Immunodeficiency Virus (HIV) in older patients has began to be observed, creating a field that has not being explored at its fullest by infectologists and geriatricians. The complications associated with the pathogenesis of the disease and the antiretroviral therapy have a great impact on bone disease, specifically the risk of suffering bone fractures.

The aim of this article is to make a compilation of the most recent evidence that supports the relation of the repercussions that the pathogenesis of HIV, the Highly Active Antiretroviral Therapy (HAART) medication and the social aspects has with the increased risk of bone fracture on HIV+ elder individuals.